ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,830Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 298

$615K Total Retail Price of All Prescriptions

Rank: 15 out of 298

471 Patients Receiving at Least One Drug in Part D
77% Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in South Dakota
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 471 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 471 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
OMEPRAZOLE 470 306 86 1 2
LEVOTHYROXINE SODIUM 296 239 60 2 1
LISINOPRIL 266 216 66 3 4
FUROSEMIDE 259 192 54 4 5
HYDROCODONE-ACETAMINOPHEN 245 123 48 S3 5 8
LOSARTAN POTASSIUM 237 199 50 6 15
SIMVASTATIN 222 205 48 7 3
AMLODIPINE BESYLATE 210 176 41 8 6
METFORMIN HCL 209 144 33 9 11
CITALOPRAM HBR 200 141 52 10 19
POTASSIUM CHLORIDE 197 161 35 11 12
TRAZODONE HCL 168 111 35 12 36
WARFARIN SODIUM 168 151 21 12 7
TAMSULOSIN HCL 167 136 29 14 21
CARVEDILOL 142 127 25 15 24
HYDROCHLOROTHIAZIDE 141 117 36 16 14
GABAPENTIN 139 96 22 17 18
PRAVASTATIN SODIUM 136 98 30 18 32
METOPROLOL SUCCINATE 131 119 30 19 13
ATORVASTATIN CALCIUM 124 119* 27 20 9
TRAMADOL HCL 120 77 32 21 16
ENALAPRIL MALEATE 112 95 19 22 70
BACLOFEN 106 22 21 23 95
KLOR-CON 10 105 55 18 24 57
LORAZEPAM 104 66 31 B 25 30
MELOXICAM 101 66 41 26 39
MONTELUKAST SODIUM 100 57 19 27 59
DONEPEZIL HCL 93 93 14 28 23
CRESTOR 92 42 16 29 25
SERTRALINE HCL 87 73 12 30 20
OXYCODONE HCL 82 41 16 S2 31 93
SPIRONOLACTONE 81 68 13 32 38
ZOLPIDEM TARTRATE 81 65 18 32 31
CLOPIDOGREL 78 63 16 34 22
SPIRIVA 78 61 15 34 50
OXYBUTYNIN CHLORIDE 78 73* 17 34 85
EVISTA 76 <11 <11 37 137
JANUVIA 75 57 11 38 64
AMOXICILLIN 74 52 54 39 128
ALLOPURINOL 73 60 16 40 27
OXYCODONE-ACETAMINOPHEN 70 31 14 S2 41 114
ATENOLOL 69 64* 16 42 17
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 52 40 43 108
VICTOZA 3-PAK 68 <11 <11 43 209
METOPROLOL TARTRATE 66 52 20 45 10
LOSARTAN-HYDROCHLOROTHIAZIDE 66 61* 18 45 46
MIRTAZAPINE 66 44 12 45 42
BUSPIRONE HCL 64 41 11 48 118
GEMFIBROZIL 64 <11 <11 48 76
METOCLOPRAMIDE HCL 63 <11 <11 50 113
RANITIDINE HCL 63 <11 <11 50 54
LANTUS SOLOSTAR 60 46 12 52 77
PREDNISONE 59 54* 30 53 34
DIOVAN 56 <11 <11 54 52
ALPRAZOLAM 56 51* 13 B 54 40
ADVAIR DISKUS 55 40 11 56 44
LYRICA 51 <11 <11 57 90
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 <11 <11 57 33
QUINAPRIL HCL 51 46* 11 57 112
LACTULOSE 50 <11 <11 60 146
NEXIUM 50 19 13 60 41
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.